Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of TERN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Terns Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Morgan Stanley | 13G | 8.10%7.10M shares | New | May 7, 20251 filing | May 7, 2025 | SEC |
| BlackRock, Inc. | 13G/A | 6.80%5.74M shares | – | Feb 5, 20251 filing | Feb 5, 2025 | SEC |
| Adage Capital Management, L.P. | 13G | 5.10%5.55M shares | New | Feb 12, 20261 filing | Feb 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Terns Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20261:32 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.21 ppfrom 5.21%Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:29 PM ET | Commodore Capital LPand 3 others | 13G/A | 1.40%1.48M shares | −5.10 ppfrom 6.50%Below 5% | Dec 31, 2025 | SEC |
| Feb 13, 20266:11 PM ET | Vivo Opportunity Fund Holdings, L.P.and 6 others | 13G/A | 2.50%2.70M shares | –Below 5% | Jan 31, 2025 | SEC |
| Feb 13, 20268:52 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 2.97%3.15M shares | −5.61 ppfrom 8.58%Below 5% | Dec 31, 2025 | SEC |
| Feb 12, 20265:01 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 0.20%212.7K shares | −9.40 ppfrom 9.60%Below 5% | Dec 31, 2025 | SEC |
| Feb 12, 20269:14 AM ET | Adage Capital Management, L.P.and 2 others | 13G | 5.10%5.55M shares | New | Dec 31, 2025 | SEC |
| Nov 14, 20254:51 PM ET | Commodore Capital LPand 3 others | 13G/A | 6.50%5.70M shares | +1.20 ppfrom 5.30% | Sep 30, 2025 | SEC |
| Nov 5, 20254:13 PM ET | OrbiMed Advisors LLCand 4 others | 13D/A | 4.80%4.24M shares | –Below 5% | Nov 3, 2025 | SEC |
| Oct 31, 202511:31 AM ET | Vanguard Group Inc | 13G | 5.21%4.56M shares | New | Sep 30, 2025 | SEC |
| Sep 16, 20256:00 PM ET | Commodore Capital LPand 3 others | 13G | 5.30%4.65M shares | New | Sep 9, 2025 | SEC |
| Aug 14, 20258:51 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.58%7.50M shares | +2.19 ppfrom 6.39% | Jun 30, 2025 | SEC |
| May 15, 20254:31 PM ET | Schonfeld Strategic Advisors LLC | 13G/A | 4.93%4.31M shares | −1.23 ppfrom 6.16%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20258:47 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.39%5.58M shares | – | Mar 31, 2025 | SEC |
| May 7, 202511:29 AM ET | Morgan Stanleyand 1 other | 13G | 8.10%7.10M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20256:25 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 4.10%3.47M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Schonfeld Strategic Advisors LLC | 13G/A | 6.16%5.23M shares | – | Dec 31, 2024 | SEC |
| Feb 11, 20254:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 9.60%8.14M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20255:28 PM ET | BlackRock, Inc. | 13G/A | 6.80%5.74M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Terns Pharmaceuticals, Inc. shares.
No Form 144 notices for Terns Pharmaceuticals, Inc. are on file.